Intrinsic Value of S&P & Nasdaq Contact Us

Augmedix, Inc. AUGX NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.67
+13.9%

Augmedix, Inc. (AUGX) is a publicly traded company in the Healthcare sector, operating within the Medical - Healthcare Information Services industry. The company is headquartered in San Francisco, CA, United States. The current CEO is Emmanuel Krakaris.

AUGX has IPO date of 2021-03-31, 1,430 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $115.91M.

About Augmedix, Inc.

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

📍 111 Sutter Street, San Francisco, CA 94104 📞 888 669 4885
Company Details
SectorHealthcare
IndustryMedical - Healthcare Information Services
CountryUnited States
ExchangeNASDAQ Capital Marke
CurrencyUSD
IPO Date2021-03-31
CEOEmmanuel Krakaris
Employees1,430
Trading Info
Current Price$2.35
Market Cap$115.91M
52-Week Range0.73-6.25
Beta-0.19
ETFNo
ADRNo
CUSIP05105P107
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message